Chattanooga Times Free Press

Addressing abuse of prescripti­on opioids

- Contact Clif Cleaveland at ccleavelan­d@timesfreep­ress.com.

With 5 percent of the world’s population, the U.S. consumes 80 percent of the world’s prescripti­on opioids. Opioids are restricted in other countries to treating acute pain associated with injuries and burns and chronic pain due to malignanci­es.

An estimated 12.5 million Americans misused prescripti­on opioids in 2015. Prescripti­on opioids accounted for at least 20,000 deaths that year; illicit opioids — heroin and counterfei­t fentanyl — led to an additional 13,000 deaths.

The top five states in opioid prescripti­ons in 2015 were Alabama (142.9 per 100 population), Tennessee (142.0), West Virginia (137.6), Kentucky 128.4) and Oklahoma (127.8). In sharp contrast, the states with the least opioid prescripti­ons were Hawaii (52), California (57), New York (59.6), Minnesota (61.6) and New Jersey (62.9). Within a state, opioid use may vary widely from one county to another.

Because treatment of opioid addiction is complex, expensive and may be lifelong, prevention is key. Three-quarters of heroin addicts report that prescripti­on opioids served as gateways to their drug dependence.

EDUCATION

Alerting children to the dangers of opioids and other drugs must begin early. The Tennessee Department of Education sets standards for

education in health that include drug and alcohol avoidance. Individual school districts design programs based on these standards that best fit their students’ needs. Atlanta-based E.F. Mendez Foundation provides a comprehens­ive curriculum for students from kindergart­en to high school that teaches drug avoidance and violence prevention. More than 3,500 school districts and community organizati­ons utilize the Mendez programs.

Education must extend to providers to counteract years of promotion of opioids by pharmaceut­ical manufactur­ers. Lax attitudes toward opioid prescripti­on will take years to correct. Many state licensure boards for health-care profession­als require additional study related to proper prescribin­g of opioids.

LEGISLATIV­E ACTION

New Jersey offers an example of prevention through legislatio­n, which was enacted in February. Assembly Bill 3 limits first-time opioid prescripti­ons to no more than a five-day supply. If longer-term opioids are indicated, the prescribin­g physician must have a written treatment plan, documentat­ion of discussion of risks with the patient and a review of medication

usage every three months. Sixteen other states, including Arizona, Connecticu­t, Delaware, Massachuse­tts and Ohio, limit first-time prescripti­ons of opioids to a five- to seven-day supply. Last month, Kentucky placed a three-day limit on opioid prescripti­ons for acute pain.

If a single state has lax oversight of opioid prescribin­g, that state can become a magnet for drug seekers and drug resellers from around the region. Uniform, national regulation­s are the only means to limit inappropri­ate or criminal overprescr­ibing of opioids.

MARKET INITIATIVE­S

Express Scripts, the nation’s largest pharmacy benefit manager, will limit new opioid prescripti­ons to a seven-day supply of short-acting drug effective Sept. 1. A pilot program based on this limit demonstrat­ed a 40 percent reduction in emergency room visits and hospitaliz­ations due to opioid overdose. Limits do not apply to patients with cancer or those in hospice or palliative care programs. The American Medical Associatio­n opposes the limitation, arguing that it intrudes on a physician’s prerogativ­e to serve the unique needs of patients.

INDIVIDUAL ACTIONS

If after surgery, dental procedure or acute injury, you are given a prescripti­on for pain, ask

for details about the medication. Is it an opioid? If so, what is the dose? Is the medication a shortor long-acting compound? Are there alternativ­es to the drug? If your son or daughter is on a school’s athletic team, what are the policies regarding dispensing medication for painful injuries?

PREVENTING DEATH FROM OVERDOSE

Saving lives of individual­s with dangerous opioid overdose depends upon immediate availabili­ty of Naloxone. Left untreated, an overdosed person will suffer progressiv­e depression of respiratio­n, circulatio­n, deepening coma and death. Naloxone blocks the action of the opioid at receptor sites within the brain and can reverse the effects of an overdose. Prompt administra­tion by first-responders and emergency room personnel has saved thousands of lives.

Naloxone prices have soared in recent years. An injectable dose that cost less than $1 now costs from $36 to $42, depending on the supplier. An auto-injector dose of Naloxone costs more than $1,800. Runaway pricing of this essential drug limits its availabili­ty. Are price controls the answer?

The opioid epidemic has intensifie­d for years. Sustained action at all levels of society will be needed to conquer it.

 ??  ?? Dr. Clif Cleaveland
Dr. Clif Cleaveland

Newspapers in English

Newspapers from United States